HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021)
HUTCHMED (China) (HCM) reported Cash from Financing Activities of $605.1 million for Q2 2021, up 4315.1% year-over-year from $13.7 million in Q2 2020, and up 2362.23% quarter-over-quarter from -$26.7 million in Q1 2021.
HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Cash from Financing Activities data on file, last reported at $605.1 million in Q2 2021.
- Cash from Financing Activities for Q2 2021 came in at $605.1 million, up 4315.1% year-over-year; the trailing twelve-month figure through Jun 2021 was $674.7 million (up 442.5% YoY), and the FY2025 annual result was $7.8 million, up 125.55% from the prior year.
- Cash from Financing Activities improved to $605.1 million in Q2 2021 per HCM's latest filing, from -$26.7 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $605.1 million in Q2 2021 and troughed at -$29.9 million in Q2 2019.
- A 4-year average of $56.8 million and a median of $379500.0 in 2018 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2019 and 2020: Cash from Financing Activities sank 328.42% in 2019, then jumped 31893.64% in 2020.
- A 4-year view of Cash from Financing Activities shows it stood at $413000.0 in 2018, then surged by 6414.04% to $26.9 million in 2019, then slumped by 153.36% to -$14.4 million in 2020, then soared by 4315.1% to $605.1 million in 2021.
- Business Quant data shows HCM's Cash from Financing Activities at $605.1 million in Q2 2021, -$26.7 million in Q1 2021, and -$14.4 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 605.08 Mn |
| Jun 30, 2021 | 605.08 Mn |
| Mar 31, 2021 | -26.75 Mn |
| Mar 31, 2021 | -26.75 Mn |
| Jun 30, 2020 | -14.36 Mn |
| Jun 30, 2020 | -14.36 Mn |
| Mar 31, 2020 | 110.70 Mn |
| Mar 31, 2020 | 110.70 Mn |
| Dec 31, 2019 | 26.90 Mn |
| Dec 31, 2019 | 26.90 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | -29.86 Mn |
| Jun 30, 2019 | -29.86 Mn |
| Mar 31, 2019 | 346,000.00 |
| Mar 31, 2019 | 346,000.00 |
| Dec 31, 2018 | 413,000.00 |
| Dec 31, 2018 | 413,000.00 |
| Sep 30, 2018 | -24,000.00 |
| Sep 30, 2018 | -24,000.00 |